Sales & Marketing Creative review: The Cannes Lions trends that pharma needs t... Pharma creative needs to stand up and be counted.
News Rebranded Servier eyes €3bn in cancer drug sales by 2030 Servier is already in the process of transforming itself into a much bigger player in cancer, and has just tripled its sales objectives for the category.
Views & Analysis 4 tips on how to navigate ‘global versus local’ challenges i... How to communicate a pharma brand identity and new product successfully, both globally and locally.
News Zymeworks cuts deal to buy Theravance for $929m in cash Zymeworks has reached a deal to buy Theravance, claiming rights to COPD therapy Yupelri, sold by Viatris, which made $267m last year.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
